1. The cognitive functions and seizure outcomes of patients with low-grade epilepsy-associated neuroepithelial tumors

   • Ming-Guo Xie
   • Jiao Qiao
   • Guoming Luan

   Research 02 September 2022 Pages: 1 - 12

   

2. Incidence trends and survival analysis of atypical meningiomas: a population-based study from 2004 to 2018

   • Matthew J. Recker
   • Cathleen C. Kuo
   • Robert J. Plunkett

   Research 11 July 2022 Pages: 13 - 22

   

3. Outcomes after gamma knife radiosurgery for intraventricular meningiomas

   • Alberto Daza-Ovalle
   • Othman Bin-Alamer
   • L. Dade Lunsford

   Research 26 July 2022 Pages: 23 - 31

   

4. Outcomes following surgical resection of cystic intracranial meningiomas

   • Alan R. Tang
   • Silky Chotai
   • Lola B. Chambless

   Research 03 August 2022 Pages: 33 - 40

   

5. Outcomes of intracranial non-germinomatous germ cell tumors: a retrospective Asian multinational study on treatment strategies and prognostic factors

   • Kyung Taek Hong
   • Jung Woo Han
   • Joo-Young Kim

   Research 31 August 2022 Pages: 41 - 53

   

6. Surgical results of 158 petroclival meningiomas with special focus on standard craniotomies

   • Gabriele Schackert
   • Miriam Lenk
   • Tareq A. Juratli

   Clinical Study Open access 14 September 2022 Pages: 55 - 65

   

7. Long non-coding RNA LINC01018 inhibits human glioma cell proliferation and metastasis by directly targeting miRNA-182-5p

   • Hu Su
   • Zhao Hailin
   • Peng Biao

   Research 12 September 2022 Pages: 67 - 78

   

8. Intrathecal therapy for the management of leptomeningeal metastatic disease: a scoping review of the current literature and ongoing clinical trials

   • Paolo Palmisciano
   • Gina Watanabe
   • Randy S. D’Amico

   Review 23 August 2022 Pages: 79 - 100

   

9. Is intracranial volume a risk factor for IDH-mutant low-grade glioma? A case–control study

   • Lisa Millgård Sagberg
   • Even Hovig Fyllingen
   • Ole Solheim

   Research Open access 27 August 2022 Pages: 101 - 106

   

10. Frameless robot-assisted stereotactic biopsy: an effective and minimally invasive technique for pediatric diffuse intrinsic pontine gliomas

    • Min Wang
    • Yi Zhang
    • Rui Zhao

    Research 23 August 2022 Pages: 107 - 114

    

11. Relapse patterns and radiation dose exposure in IDH wild-type glioblastoma at first radiographic recurrence following chemoradiation

    • Satoka Shidoh
    • Ricky R. Savjani
    • Benjamin M. Ellingson

    Research Open access 02 September 2022 Pages: 115 - 125

    

12. Meningioma in patients exposed to progestin drugs: results from a real-life screening program

    • Thomas Samoyeau
    • Corentin Provost
    • Joseph Benzakoun

    Research 06 September 2022 Pages: 127 - 136

    

13. miR-497 and 219 in blood aid meningioma classification

    • Ahmed Abdelrahman
    • Caterina Negroni
    • Clemens Oliver Hanemann

    Research 08 September 2022 Pages: 137 - 147

    

14. Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3

    • Jonathan Weller
    • Sophie Katzendobler
    • Joerg-Christian Tonn

    Research Open access 16 September 2022 Pages: 149 - 158

    

15. Roles and outcomes of stereotactic biopsy for adult patients with brainstem lesion

    • Henri Malaizé
    • Florence Laigle-Donadey
    • the PSL BRAIN-BIOPSY STUDY GROUP

    Research 09 September 2022 Pages: 159 - 170

    

16. Racial disparities in pediatric malignant glioma management: current state of affairs in the United States

    • Victor M. Lu
    • Toba N. Niazi

    Research 08 September 2022 Pages: 171 - 178

    

17. The utility of DNA methylation analysis in elderly patients with pilocytic astrocytoma morphology

    • Yasuki Suruga
    • Kaishi Satomi
    • Isao Date

    Case Study 15 September 2022 Pages: 179 - 189

    

18. Radiotherapy or systemic therapy versus combined therapy in patients with brain metastases: a propensity-score matched study

    • Yutaro Koide
    • Naoya Nagai
    • Takeshi Kodaira

    Research 16 September 2022 Pages: 191 - 200

    

19. Stereotactic radiosurgery for Koos grade IV vestibular schwannoma in young patients: a multi-institutional study

    • Chloe Dumot
    • Stylianos Pikis
    • Jason P. Sheehan

    Research 27 September 2022 Pages: 201 - 208

    

20. Changes in survival over time for primary brain and other CNS tumors in the United States, 2004–2017

    • Gino Cioffi
    • Kristin A. Waite
    • Jill S. Barnholtz-Sloan

    Research Open access 05 October 2022 Pages: 209 - 219

    

21. Postmortem study of organ-specific toxicity in glioblastoma patients treated with a combination of temozolomide, irinotecan and bevacizumab

    • Guangrong Lu
    • Ping Zhu
    • Jay-Jiguang Zhu

    Clinical Study 06 October 2022 Pages: 221 - 231

    

22. Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer

    • Caressa Hui
    • Vera Qu
    • Erqi Pollom

    Research 13 October 2022 Pages: 233 - 240

    

23. A quantitative characterization of the spatial distribution of brain metastases from breast cancer and respective molecular subtypes

    • Saeedeh Mahmoodifar
    • Dhiraj J. Pangal
    • Paul K. Newton

    Research 16 October 2022 Pages: 241 - 251

    

24. Pre-operative MRI radiomics model non-invasively predicts key genomic markers and survival in glioblastoma patients

    • Mathew Pease
    • Zachary C. Gersey
    • P. O. Zinn

    Research 14 October 2022 Pages: 253 - 263

    

25. Proposing a quantitative MRI-based linear measurement framework for response assessment following stereotactic body radiation therapy in patients with spinal metastasis

    • Pejman Jabehdar Maralani
    • Hanbo Chen
    • Arjun Sahgal

    Research 07 October 2022 Pages: 265 - 272

    

26. Letter: Does the “hospital frailty risk score” measure preoperative frailty for craniopharyngioma surgery?

    • Joshua Marquez
    • Meic Schmidt
    • Christian A. Bowers

    Correspondence 12 October 2022 Pages: 273 - 275